Impaired FHIT Expression in Ovarian Cancer
Author Information
Author(s): Ozaki K, Enomoto T, Yoshino K, Fujita M, Buzard G S, Kawano K, Yamasaki M, Murata Y
Primary Institution: Osaka University Faculty of Medicine
Hypothesis
The FHIT gene plays a role in the development of ovarian cancer.
Conclusion
The study found that loss of FHIT gene expression is associated with the development of high-grade serous ovarian carcinoma.
Supporting Evidence
- Aberrant FHIT transcripts were found in 15% of ovarian carcinomas.
- Loss of normal FHIT transcript was observed in 15% of carcinomas.
- Impaired expression of Fhit protein was found in 14% of ovarian carcinomas.
- Loss of FHIT expression was significantly correlated with the loss of normal FHIT transcription.
- Loss of normal FHIT transcript occurred only in high-grade serous adenocarcinomas.
Takeaway
This study looked at a gene called FHIT in ovarian cancer and found that when this gene doesn't work properly, it might help cancer grow.
Methodology
The study examined FHIT gene alterations in ovarian carcinomas, borderline tumors, and benign adenomas using RT-PCR, sequencing, and immunohistochemistry.
Participant Demographics
The study included 33 ovarian carcinomas, 2 borderline tumors, and 10 benign adenomas.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website